Headlands Technologies LLC Boosts Stake in GE HealthCare Technologies Inc. $GEHC

Headlands Technologies LLC boosted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 499.9% in the 2nd quarter, Holdings Channel reports. The firm owned 58,990 shares of the company’s stock after buying an additional 49,157 shares during the quarter. Headlands Technologies LLC’s holdings in GE HealthCare Technologies were worth $3,776,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of GEHC. Wedbush Securities Inc. grew its stake in shares of GE HealthCare Technologies by 17.0% during the second quarter. Wedbush Securities Inc. now owns 4,349 shares of the company’s stock valued at $278,000 after buying an additional 632 shares during the last quarter. Spinnaker Trust lifted its stake in shares of GE HealthCare Technologies by 60.1% during the 2nd quarter. Spinnaker Trust now owns 74,005 shares of the company’s stock worth $4,737,000 after acquiring an additional 27,772 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in GE HealthCare Technologies by 0.8% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,541,393 shares of the company’s stock valued at $162,675,000 after acquiring an additional 20,180 shares during the period. New Mexico Educational Retirement Board boosted its holdings in GE HealthCare Technologies by 7.6% during the 2nd quarter. New Mexico Educational Retirement Board now owns 22,692 shares of the company’s stock valued at $1,453,000 after acquiring an additional 1,600 shares during the period. Finally, Mufg Securities Americas Inc. grew its position in GE HealthCare Technologies by 8.6% in the 2nd quarter. Mufg Securities Americas Inc. now owns 13,701 shares of the company’s stock valued at $877,000 after acquiring an additional 1,090 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 0.0%

GEHC opened at $71.72 on Monday. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.92. The stock’s fifty day moving average is $67.67 and its two-hundred day moving average is $69.26. The company has a market capitalization of $32.39 billion, a P/E ratio of 16.45, a PEG ratio of 2.07 and a beta of 0.69. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, July 29th. The company reported $1.13 earnings per share for the quarter, topping the consensus estimate of $1.04 by $0.09. GE HealthCare Technologies had a return on equity of 20.12% and a net margin of 9.33%.The business had revenue of $5.29 billion during the quarter, compared to analysts’ expectations of $5.26 billion. During the same period in the prior year, the business earned $1.06 EPS. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. Analysts forecast that GE HealthCare Technologies Inc. will post 4.93 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Friday, July 24th were paid a $0.035 dividend. The ex-dividend date of this dividend was Friday, July 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is 3.21%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on GEHC. Argus reduced their target price on GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating on the stock in a research note on Tuesday, May 19th. Hovde Group assumed coverage on shares of GE HealthCare Technologies in a research note on Friday, July 17th. They set a “market perform” rating and a $14.00 target price for the company. Weiss Ratings restated a “hold (c-)” rating on shares of GE HealthCare Technologies in a report on Wednesday, August 12th. Piper Sandler reaffirmed a “buy” rating on shares of GE HealthCare Technologies in a research note on Wednesday, July 29th. Finally, Royal Bank Of Canada began coverage on shares of GE HealthCare Technologies in a report on Tuesday, June 23rd. They set an “outperform” rating and a $80.00 price objective for the company. Ten investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Hold” and a consensus price target of $77.73.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.